Celldex Therapeutics reported -0.34 in EPS Earnings Per Share for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Abbvie ABBV:US $ 0K 0K
Agenus AGEN:US -0.37 0.1
Amgen AMGN:US $ 4.38 0.68
Applied Genetic Technologies AGTC:US -0.28 0.12
Aptinyx Inc APTX:US -0.29 0.07
Arena Pharmaceuticals ARNA:US -2.4 0.42
Biocept BIOC:US $ -0.14 0.33
Bristol Myers Squibb BMY:US $ 1.93 0.19
Celldex Therapeutics CLDX:US -0.34 0.08
Glaxosmithkline GSK:US $ 0.79 0.16
Immunogen IMGN:US -0.15 0.02
Nektar Therapeutics NKTR:US $ -0.69 0.02
Newlink Genetics NLNK:US -1.04 0
Pfizer PFE:US $ 1.07 0.14
Rigel Pharmaceuticals RIGL:US -0.08 0.3
Seattle Genetics SGEN:US $ -0.47 0.2